Characteristics, resource utilization and safety profile of patients prescribed with neuropathic pain treatments: a real-world evidence study on general practices in Europe.
CONCLUSIONS: Evidence from daily clinical practice in GP settings agree with the findings from more controlled clinical-trial settings, with lidocaine 5% medicated plaster patients showing a better safety profile, but also a comparable level of resource utilization. A possible re-evaluation of the scientific value coming from this retrospective study in building up diagnostic as well as therapeutic algorithm is suggested.
PMID: 28537441 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
More News: Amitriptyline | Brain | Clinical Trials | Cymbalta | Databases & Libraries | Drugs & Pharmacology | Gabapentin | General Practices | Lidoderm | Lyrica | Neurology | Neurontin | Neuroscience | Pain | Research | Study